Trinity Biotech Plc Share Price

NASDAQ: TRIB

Small Cap

$1.21

+0.03

(+2.56%)

Live

as on September 18, 2025 at 9:31 pm IST

$₹

Trinity Biotech Plc Stock Performance

as on September 18, 2025 at 9:31 pm IST

Day's Low
Day's High
$1.2
Day's Price Range
$1.25
$1.21
0.83%
Downside
3.31%
Upside
52 Week's Low
52 Week's High
$0.54
52-Week Price Range
$11.05
$1.21
55.59%
Downside
813.22%
Upside

Trinity Biotech Plc share price movements today

Previous Close: $1.18
Open: $1.24
Volume: 120.6K
Day's Low - High: $1.2 - $1.25
52 Week Low - High: $0.54 - $11.05

Trinity Biotech Plc Historical Returns

1 Month Return: -24.84 %
3 Month Return: + 106.15 %
1 Year Return: -84.27 %
3 Year Return: -96.1 %
5 Year Return: -97.98 %

Trinity Biotech Plc Stock Fundamentals & Key Indicators

Check Trinity Biotech Plc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$22.4M

EPS (TTM)

0

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

-0.77%

PE Ratio (TTM)

0

P/B Ratio

0

PEG Ratio

1.3

EBITDA

-13.0M

Revenue (TTM)

61.6M

Profit Margin

-51.64%

Return On Equity TTM

64028500.00%

Trinity Biotech Plc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Trinity Biotech Plc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Trinity Biotech Plc	BUY	$22.4M	-97.98%	NA	-51.64%
Boston Scientific Corp.	BUY	$146.0B	155.98%	58.63	13.55%
Stryker Corporation	BUY	$144.1B	82.61%	49.98	12.25%
Abbott Laboratories	BUY	$233.5B	25.56%	16.83	32.43%
Medtronic Plc	BUY	$121.3B	-12.1%	26.13	13.63%

See all

Stock Returns calculator for Trinity Biotech Plc Stock including INR - Dollar returns

The Trinity Biotech Plc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

1Y
3Y
5Y
7Y
10Y

Trinity Biotech Plc investment value today

Current value as on today

₹21,087

Returns

₹78,913

(-78.91%)

Returns from Trinity Biotech Plc Stock

₹83,867 (-83.87%)

Dollar Returns*

₹4,953 (+4.95%)

Analyst Recommendation on Trinity Biotech Plc Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Trinity Biotech Plc. Average target price of $3

Trinity Biotech Plc Share Price Target

Get share price movements and forecasts by analysts on Trinity Biotech Plc.

What analysts predicted

59.67%UPSIDE

Target Price

$3

Current Price

$1.21

Analyzed by

7 Analysts

Target

$3.00

Trinity Biotech Plc target price $3, a slight upside of 59.67% compared to current price of $1.21. According to 7 analysts rating.

Trinity Biotech Plc Stock's Interest Amongst Investors

Investment in Trinity Biotech Plc Shares on INDmoney has dropped by -28.10% over the past 30 days, indicating reduced transactional activity.

Time period: August 19, 2025 to September 18, 2025

Change:-28.10% versus previous 30 day period

Search interest for Trinity Biotech Plc Stock has decreased by -6% in the last 30 days, reflecting a downward trend in search activity.

Time period: August 19, 2025 to September 18, 2025

Change:-6% versus previous 30 day period

Trinity Biotech Plc Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024
Total Revenue	18	18	14	13	14	14	14	15	15	15
Gross Profit	6	6	5	5	4	4	4	5	5	4
Operating Income	-4	-4	-3	-14	-4	-3	-3	-1	-2	-11
EBITDA	-7	-7	-3	-14	-3	-2	-2	-	-1	-9
Interest Expense	2	2	2	3	2	0	0	5	3	5
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-10	-10	-6	-18	-6	-3	-3	-6	-4	-15
Income Tax Expense	0	0	0	0	0	0	0	-	0	0
Net Income	-10	-10	-6	-5	-6	-3	-3	-6	-4	-16
Net Profit Margin	-55.87%	-55.87%	-42.52%	-43.09%	-45.79%	-22.56%	-22.56%	-42.65%	-31.41%	-106.93%

Trinity Biotech Plc Annual Profit & Loss

All numbers in Millions USD

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	100	99	99	97	90	101	92	74	56	61
Gross Profit	46	43	41	41	38	48	38	22	19	21
Operating Income	13	7	5	3	0	19	13	-10	-27	-21
EBITDA	19	-30	-29	-13	-19	21	10	-16	-24	-16
Interest Expense	3	4	5	5	5	6	7	24	10	11
Depreciation	-	-	5	4	4	3	2	2	1	1
Income Before Tax	22	5	1	3	0	-6	0	-41	-36	-30
Income Tax Expense	1	0	0	0	4	0	0	0	0	0
Net Income	21	-100	-40	2	-4	-6	0	-41	-24	-31
Net Profit Margin	21.75%	-101.02%	-40.62%	2.46%	-4.50%	-5.90%	0.94%	-54.83%	-42.26%	-51.64%

Trinity Biotech Plc Quarterly Cash Flow

All numbers in Millions USD

	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024
Net Income	-10	-5	-5	-6	-3	-3	-6	-4	-16
Operating Cash Flow	2	-2	-4	-4	-4	-4	-1	-3	3
Investing Cash Flow	-1	-1	27	0	-	-13	-	-3	-2
Financing Cash Flow	-1	1	-13	-2	20	20	3	4	1
Change in Cash	0	-2	10	-7	2	2	0	-2	2

Trinity Biotech Plc Annual Cash Flow

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	16	12	13	12	-6	0	-41	-24	-31
Operating Cash Flow	13	12	6	5	23	13	0	-11	-4
Investing Cash Flow	-22	-16	-17	-15	-10	-8	-5	24	-22
Financing Cash Flow	-16	-15	-16	-3	-2	-6	-12	-16	28
Change in Cash	-24	-19	-27	-13	10	-1	-19	-2	1

Global Institutional Holdings in Trinity Biotech Plc

Funds	Holdings
Hunter Associates Inc.	2.01%
Whitefort Capital Management, LP.	0.44%
Renaissance Technologies Corp	0.41%
HRT FINANCIAL LLC	0.36%
Citadel Advisors Llc	0.22%

See all

Insights on Trinity Biotech Plc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 15.15M → 15.85M (in $), with an average increase of 4.5% per quarter
NO EFFECT
Against Peers
In the last 3 years, Boston Scientific Corp. has given 136.2% return, outperforming this stock by 232.3%
NO EFFECT
Against Peers
In the last 1 year, Boston Scientific Corp. has given 19.3% return, outperforming this stock by 103.6%
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, -4.75M → -16.95M (in $), with an average decrease of 256.3% per quarter
NEGATIVE IMPACT
Price Dip
In the last 1 month, TRIB stock has moved down by -24.8%

About Trinity Biotech Plc

since its formation in 1992, trinity biotech has actively pursued the aim of becoming a leading player in the international diagnostics industry. through a combination of sustained, organic growth and an acquisition-led strategy, the company has assembled an impressive product portfolio and achieved the highest standards of excellence in developing, manufacturing and marketing diagnostic products. the test kits manufactured by trinity biotech are used in the clinical laboratory and point-of-care segments of the diagnostic market to detect infectious diseases, sexually transmitted diseases, autoimmune and haemoglobin disorders, and detect, monitor and control diabetes. the company is also a significant provider of raw materials to the life sciences industry. trinity biotech, which has its headquarters in ireland, employs in excess of 350 people and markets its portfolio of over 400 products to customers in 80 countries around the world. it reaches this worldwide market by combining the

Organisation	Trinity Biotech Plc
Headquarters	IDA Business Park, Bray, Ireland, A98 H5C8
Industry	Health Technology
CEO	Mr. John Gillard
E-voting on shares	Click here to vote

Key Management of Trinity Biotech Plc

Name	Title
Mr. John Gillard	President, CEO, Company Secretary & Director
Mr. Ronan O'Caoimh A.C.A.	Founder, Director & Executive Advisor
Dr. James Walsh Ph.D.	Executive Director of Business Development & Executive Director
Ms. Susan O'Connor	Interim Chief Financial Officer
Ms. Jacqueline O'Neill	Director of Operations
Ms. Louise Tallon	Chief Accounting Officer
Mr. Adrian Donohue	Chief Commercial Officer
Dr. Gary Keating Ph.D.	Chief Technology Officer
Ms. Eibhlin Kelly	Chief Information Officer
Mr. Colm Molloy	Group Director of Human Resources & Culture

FAQs

What is Trinity Biotech Plc share price today?

Trinity Biotech Plc share price today is $1.21 as on September 18, 2025 at 9:31 pm IST. Trinity Biotech Plc share today touched a day high of $1.25 and a low of $1.2.

What is the 52 week high and 52 week low for Trinity Biotech Plc share?

Trinity Biotech Plc share touched a 52 week high of $11.05 on October 28, 2024 and a 52 week low of $0.54 on June 20, 2025. Trinity Biotech Plc stock price today i.e. September 18, 2025 at 9:31 pm IST is trending at $1.21,which is 89.05% down from its 52 week high and 125.20% up from its 52 week low.

What is Trinity Biotech Plc's market capitalisation today?

Trinity Biotech Plc market capitalisation is $0.00T as on September 18, 2025 at 9:31 pm IST.

How to invest in Trinity Biotech Plc Stock (TRIB) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Trinity Biotech Plc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Trinity Biotech Plc Shares that will get you 1.2397 shares as per Trinity Biotech Plc share price of $1.21 per share as on September 18, 2025 at 9:31 pm IST.

What is the minimum amount required to buy Trinity Biotech Plc Stock (TRIB) from India?

Indian investors can start investing in Trinity Biotech Plc (TRIB) shares with as little as ₹88.114 or $1 (as of September 18, 2025 at 9:42 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹881.14 in Trinity Biotech Plc stock (as per the Rupee-Dollar exchange rate as on September 18, 2025 at 9:42 pm IST). Based on Trinity Biotech Plc share’s latest price of $1.21 as on September 18, 2025 at 9:31 pm IST, you will get 8.2645 shares of Trinity Biotech Plc. Learn more about fractional shares .

What are the returns that Trinity Biotech Plc has given to Indian investors in the last 5 years?

Trinity Biotech Plc stock has given -97.98% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?